Monocyte-induced Inhibition of Lymphocyte Response to Phytohaemagglutinin in Progressive Systemic Sclerosis

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 1983 Feb 1

PMID 6600913

Citations 2

Authors

M D Lockshin

J A Markenson

L Fuzesi

S Kazanjian-Aram

C Joachim

M Ordene

Affiliations

Soon will be listed here.

Abstract

In patients with progressive systemic sclerosis (PSS) lymphocyte responses to phytohaemagglutinin (PHA) are abnormal (27.2 +/- 3.5 X 10(-3) counts per minute (cpm) versus 69.8 +/- 4.4 X 10(-3) for normal persons, p less than 0.005). Removal of adherent peripheral blood mononuclear cells improves the response of PSS lymphocytes (42.3 +/- 3.4 X 10(-3) cpm, 155% of control) but diminishes the response of normal lymphocytes (60.3 +/- 5.9 +/- 10(-3), 86% of control). Supernatant fluids from cultures of PSS unfractionated and adherent cells depress normal T cell response to PHA (64% and 55% of control respectively), but supernatant fluids from normal unfractionated and adherent cells do not (104% and 101% of control). Supernatant fluids of PSS and normal adherent cells, cultured in the presence of indomethacin, are not inhibitory to normal T cells (109 +/- 15% and 124 +/- 14% of control respectively). Supernatant fluids from PSS patients are more inhibitory than comparable fluids from patients with systemic lupus erythematosus (60 +/- 8% of control versus 80 +/- 5% of control). These data support the hypothesis that cellular immunity is abnormal in patients with PSS and indicate that adherent mononuclear cells mediate at least one component of the abnormality via an indomethacin-sensitive mechanism.

Citing Articles

Increased interferon-gamma (IFN-gamma) levels produced in vitro by alloactivated T lymphocytes in systemic sclerosis and Raynaud's phenomenon.

Molteni M, Della Bella S, Mascagni B, Bazzi S, Zulian C, Compasso S Clin Exp Immunol. 1999; 116(1):164-8.

PMID: 10209521 PMC: 1905213. DOI: 10.1046/j.1365-2249.1999.00842.x.

Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Sternberg E Surv Immunol Res. 1985; 4(1):69-80.

PMID: 3890057 DOI: 10.1007/BF02918588.

References

Rothfield N, Rodnan G . Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1968; 11(5):607-17. DOI: 10.1002/art.1780110502. View

Yam L, Li C, CROSBY W . Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971; 55(3):283-90. DOI: 10.1093/ajcp/55.3.283. View

von Boehmer H, Shortman K . The separation of different cell classes from lymphoid organs. IX. A simple and rapid method for removal of damaged cells from lymphoid cell suspensions. J Immunol Methods. 1973; 2(3):293-301. DOI: 10.1016/0022-1759(73)90055-0. View

Hughes P, Holt S, ROWELL N . Leukocyte migration inhibition in progressive systemic sclerosis. Br J Dermatol. 1974; 91(1):1-6. DOI: 10.1111/j.1365-2133.1974.tb06709.x. View

Alarcon-Segovia D, FISHBEIN E, Estrada-Parra S . Uracil-specific anti-R.N.A. antibodies in scleroderma. Lancet. 1975; 1(7903):363-6. DOI: 10.1016/s0140-6736(75)91279-9. View

Alarcon-Segovia D, FISHBEIN E . Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. I. Differences in reactivity with Poly (U) and Poly-(A) Poly (U). J Immunol. 1975; 115(1):28-31. View

De Jesus D, Clancy R . Circulating T and B lymphocytes in progressive systemic sclerosis. J Rheumatol. 1975; 2(3):336-9. View

Salem N, Morse J . Lymphocyte response to mitogens in progressive systemic sclerosis. Arthritis Rheum. 1976; 19(5):875-82. DOI: 10.1002/art.1780190507. View

Stuart J, Postlethwaite A, Kang A . Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med. 1976; 88(4):601-7. View

10.

Horwitz D, Garrett M . Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol. 1977; 27(1):92-9. PMC: 1540894. View

11.

Moretta L, Webb S, Grossi C, Lydyard P, Cooper M . Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med. 1977; 146(1):184-200. PMC: 2180738. DOI: 10.1084/jem.146.1.184. View

12.

Goodwin J, Messner R, Bankhurst A, Peake G, Saiki J, Williams Jr R . Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977; 297(18):963-8. DOI: 10.1056/NEJM197711032971802. View

13.

Goodwin J, Bankhurst A, Messner R . Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med. 1977; 146(6):1719-34. PMC: 2181914. DOI: 10.1084/jem.146.6.1719. View

14.

Lawley T, Peck G, Moutsopoulos H, Gratwohl A, Deisseroth A . Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med. 1977; 87(6):707-9. DOI: 10.7326/0003-4819-87-6-707. View

15.

Markenson J, Morgan J, Lockshin M, Joachim C, Winfield J . Responses of fractionated cells from patients with systemic lupus erythematosus and normals to plant mitogen: evidence for a suppressor population of monocytes. Proc Soc Exp Biol Med. 1978; 158(1):5-9. DOI: 10.3181/00379727-158-40127. View

16.

Gupta S, GOOD R . Subpopulations of human T lymphocytes. V. T lymphocytes with receptors for immunoglobulin M or G in patients with primary immunodeficiency disorders. Clin Immunol Immunopathol. 1978; 11(3):292-302. DOI: 10.1016/0090-1229(78)90053-3. View

17.

Ellner J . Suppressor adherent cells in human tuberculosis. J Immunol. 1978; 121(6):2573-9. View

18.

Cooper S, Harding B, Mirick G, Schneider J, Quismorio F, Friou G . Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis. Clin Exp Immunol. 1978; 34(2):235-40. PMC: 1537498. View

19.

Trompeter R, Layward L, Hayward A . Primary and secondary abnormalities of T cell subpopulations. Clin Exp Immunol. 1978; 34(3):388-92. PMC: 1537549. View

20.

Goodwin J, DeHoratius R, Israel H, Peake G, Messner R . Suppressor cell function in sarcoidosis. Ann Intern Med. 1979; 90(2):169-73. DOI: 10.7326/0003-4819-90-2-169. View